Sucrose octasulfate dressing vs control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): An international, multicentre, double-blind, randomised, controlled trial
The Lancet Diabetes & Endocrinology Mar 01, 2018
Edmonds M, et al. - Experts sought to comparatively gauge the upshot of a sucrose octasulfate dressing vs a control dressing on wound closure in patients with neuroischaemic diabetic foot ulcers. A marked improvement was achieved in the wound closure of neuroischaemic diabetic foot ulcers via a sucrose octasulfate dressing, without affecting safety after 20 weeks of treatment along with standard care. Hence, yielded data validated the use of sucrose octasulfate dressing as a local treatment for neuroischaemic diabetic foot ulcers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries